Sort by
Refine Your Search
-
China Spallation Neutron Source (CSNS) is one of China's leading national research facilities for materials science. It produces neutrons with an accelerator-based system that delivers proton pulses
-
the field of x-ray spectroscopy of two-dimensional magnetic materials. The goal is the characterisation of these materials in the few- or single-monolayer limit and their controlled manipulation by external
-
) Microelectronics and Telecommunications; (4) Electronic and Energy Devices. EIE Program Homepage:https://en-soe.westlake.edu.cn/OurSchool/program/programEIE/ Program 5: Materials Science and Engineering (MSE). Areas
-
to bear on these problems: biochemistry, molecular biology, cell biology, microfluidics, cross-linking/mass spectrometry, artificial intelligence, and protein design. Postdocs will have the opportunity
-
: algebra, number theory, lattice theory and lattice cryptography, quantum information and quantum transformation. Computer Science: Database application development, Data modeler et al. Candidates of all
-
, Energy-related chemistry, Energy-related material sciences, and Nano-sciences. Refer to the following URL though the application for October 2024 enrollment had been closed. Applications guideline in
-
who have proven capacity or clear potential to bring externally sponsored research to Texas Tech University are highly encouraged to apply. Faculty Qualifications Ph.D. in Chemistry, Materials Science
-
The School of Life Sciences at Peking University has a rich history dating back to 1925. Over the years, the School has grown into one of China's leading biology institutions, known for its
-
on investigating the genetics and molecular biology of cancer, as well as the immune system, with the goal of devising and developing novel immunotherapies. This is an exciting opportunity to work in a dynamic and
-
pharmacology, pharmacogenetics/genomics, pharmacometrics, and quantitative systems pharmacology. It will serve as a bridge between the discovery sciences and the use of novel pharmacological interventions